Board Meetings for INDOUS

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
INDOUSIndo Us Biotech Limited29 May 2026Financial ResultsTo consider and approve the financial results for the period ended March 31, 2026
INDOUSIndo Us Biotech Limited29 May 2026Board Meeting IntimationINDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
INDOUSIndo Us Biotech Limited21 Jan 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
INDOUSIndo Us Biotech Limited21 Jan 2026Board Meeting IntimationINDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 21-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
INDOUSIndo Us Biotech Limited14 Nov 2025Board Meeting IntimationINDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .
INDOUSIndo Us Biotech Limited14 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
INDOUSIndo Us Biotech Limited14 Oct 2025Other business mattersNotice is hereby given pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( LODR ) that a meeting of the Board of Directors of the Company at Shorter Notice will be held on Tuesday 14th October, 2025 inter-alia, to transect the following business: 1. To consider and approve the re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company,2. To approve Notice of Postal Ballot3. Appoint M/s. Amrish Gandhi & Associates, Practising Company Secretary scrutinizer to scrutinize the e-voting process in a fair and transparent manner for the postal ballot.4. Any other businessesThe meeting is being convened on a shorter notice as permitted under the provisions of the Companies Act, 2013. However, we confirm compliance with the SEBI LODR Regulations regarding timely intimation of the meeting to the Stock Exchange(s).This intimation is being made in compliance with the applicable provisions of the SEBI (LODR) Regulations, 2015.We request you to kindly take the above information on record.
INDOUSIndo Us Biotech Limited12 Aug 2025Board Meeting IntimationINDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .
INDOUSIndo Us Biotech Limited12 Aug 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
INDOUSIndo Us Biotech Limited26 May 2025Financial ResultsTo consider and approve the financial results for the period ended March 31, 2025
INDOUSIndo Us Biotech Limited26 May 2025Board Meeting IntimationINDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 26-May-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2025 .
INDOUSIndo Us Biotech Limited11 Feb 2025Board Meeting IntimationINDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 11-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
INDOUSIndo Us Biotech Limited11 Feb 2025Financial ResultsTo consider and approve the financial results for the period ended December 31, 2024
INDOUSIndo Us Biotech Limited21 Nov 2024Board Meeting IntimationINDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 21-Nov-2024 to consider Dividend.
INDOUSIndo Us Biotech Limited21 Nov 2024DividendINDOUS : 21-Nov-2024 : The Company has informed the Exchange that a Board meeting to be held on November 16, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 21, 2024, To consider dividend
Showing page 1 of 2 (19 total items)
Next